-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
<>
As the world's first SMA disease modification treatment drug, Noxinagen Sodium was "insured" for the first time and received widespread attention from the society
China speeds up the last mile of medical insurance medication in one month
With the continuous deepening of medical insurance reform, the time for the implementation of medical insurance policies has also been shortened year by year
High-value rare disease drugs are included in the medical insurance drug list for the first time , demonstrating that the Chinese government attaches great importance to drug protection for patients with rare diseases
The low accessibility of rare disease drugs enrolled in the insurance "break-through" helps improve the level of diagnosis and treatment of SMA
As the doctor who prescribed the first batch of prescriptions for Nocinnasheng Sodium Injection after entering the medical insurance catalogue, Professor Zhong Jianmin, Department of Neurology , Jiangxi Children’s Hospital, said : “SMA is currently the number one genetic disease killer for infants under two years old.
Noxinagen sodium is an antisense oligonucleotide drug that accurately targets the cause of SMA, effectively improves patient's vital functions such as exercise and breathing, improves survival rate, and changes the disease process of SMA
All parties work together to provide the best New Year gifts for SMA patients
On New Year's Day, medical staff in various medical institutions gave up the holiday break and worked overtime to treat SMA patients
Xing Huanping, executive director of the patient organization Meier SMA Care Center, said: " As a member of the SMA Patient Care Center, we have witnessed that the patient group has gone from no medicine to hope of treatment, and now enjoys the medical insurance policy, and the family burden is greatly reduced
This month, the medical insurance policy of Nosina Sodium will be successively implemented in more than 20 provinces and cities across the country.